CPC A61M 35/00 (2013.01) [A61M 2205/3303 (2013.01); A61M 2205/3317 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/52 (2013.01); A61M 2205/6072 (2013.01); A61M 2230/04 (2013.01)] | 4 Claims |
1. An intelligent bioelectric module for use with a drug delivery system, the drug delivery system having first and second surface regions, wherein the first surface region is configured for contact with a tissue surface of a human or animal subject, the module comprising:
a case;
a set of at least two electrodes in electrical communication with a detection surface of the case, wherein a set of dielectric materials is disposed between the detection surface and the electrodes;
wherein the case is configured so that, in use, the detection surface comes into electrical communication with a member selected from the group consisting of (i) the second surface region of the drug delivery system, (ii) the tissue surface that is adjacent to a portion contacted by the first surface region of the drug delivery system, and (iii) combinations thereof; and
electronics disposed within the case that determines if a quantity related to impedance to an AC signal is within a predetermined limit, wherein the impedance to the AC signal is experienced over a path that includes (a) the set of electrodes and (b) material in a location selected from the group consisting of the second surface region, the tissue surface, and combinations thereof;
wherein, if the impedance to the AC signal is determined to be within the predetermined limit, the drug delivery system is determined to be coupled to tissue as opposed to non-living material.
|